Medical application of functionalized magnetic nanoparticles

Journal of Bioscience and Bioengineering

Volumn 100, Issue 1, 2005, Pages 1-11

  Ito, Akira ^a   Shinkai, Masashige ^b   Honda, Hiroyuki ^a   Kobayashi, Takeshi ^c  

^a NAGOYA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c CHUBU UNIVERSITY   (Japan)

Author keywords

Drug delivery system; Hyperthermia; Magnetic nanoparticle; Magnetic resonance imaging; Tissue engineering

Indexed keywords

ANTIBODIES; CELLS; DRUG DOSAGE; MAGNETIC RESONANCE IMAGING; MEDICAL APPLICATIONS; TISSUE; TUMORS;

DRUG DELIVERY SYSTEM; HYPERTHERMIA; MAGNETIC NANOPARTICLES;

NANOSTRUCTURED MATERIALS;

ANTIBODY CONJUGATE; CATION; LIPOSOME; MAGNETITE; NANOPARTICLE;

CANCER THERAPY; CELL STRUCTURE; CELL SURFACE; HEATING; HUMAN; HYPERTHERMIC THERAPY; MAGNETISM; MEDICAL TECHNOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; TARGET CELL; TISSUE ENGINEERING;

EID: 27644542061     PISSN: 13891723     EISSN: None     Source Type: Journal    
DOI: 10.1263/jbb.100.1     Document Type: Article

References (80)

1. Dunnill, P. and Lilly, M. D.: Purification of enzymes using magnetic bioaffinity materials. Biotechnol. Bioeng., 16, 987-990 (1974).
2. Mosbach, K. and Anderson, L.: Magnetic ferrofluids for prepareation of magnetic polymers and their application in affinity chromatography. Nature, 270, 259-261 (1977).
3. Stechell, C. H.: Magnetic separations in biotechnology - a review. J. Chem. Technol. Biotechnol., 35B, 175-182 (1985).
4. Kondo, A., Kamura, H., and Higashitani, K.: Development and application of thermosensitive magnetic immunomicrospheres for antibody purification. Appl. Microbiol. Biotechnol., 41, 99-105 (1994).
5. Kondo, A. and Fukuda, H.: Preparation of thermo-sensitive magnetic hydrogel microspheres and application to enzyme immobilization. J. Ferment. Bioeng., 84, 337-341 (1997).
6. Häfeli, U., Shutt, W., Teller, J., and Zborowski, M. (ed.): Scientific and clinical application of magnetic carriers. Plenum Press, New York (1997).
7. Safarik, I. and Safarikova, M.: Use of magnetic techniques for isolation of cells. J. Chromatogr. B Biomed. Sci. Appl., 722, 33-53 (1999).
8. Saiyed, Z. M., Telang, S. D., and Racnchand, C. N.: Application of magnetic techniques in the field of drug discovery and biomedicine. Biomagn. Res. Technol., 1, 23-33 (2003).
9. Safarik, I. and Safarikova, M.: Magnetic techniques for the isolation and purification of proteins and peptides. Biomagn. Res. Technol., 2, 7-34 (2004).
10. Liu, C.-Z., Honda, H., Ohshima, A., Shinkai, M., and Kobayashi, T.: Development of chitosan-magnetite aggregates containing Nitrosomonas europaea cells for nitrification enhancement. J. Biosci. Bioeng., 89, 420-425 (2000).
11. Barclay, A. N., Brown, M. L., Beyers, A. D., Davis, S. J., Somoza, C., and Williams, A. F.: The leukocytes antigen facts book. Academic Press, San Diego, CA (1993).
12. Weber, C. and Falkenhagen, D.: Specific blood purification by means of antibody-conjugated magnetic microspheres, p. 371-378. In Häfeli, U., Shutt, W., Teller, J., and Zborowski, M. (ed.), Scientific and clinical application of magnetic carriers. Plenum Press, New York (1997).
13. Guesdon, J. L., Thiery, R., and Avrameas, S.: Magnetic enzyme immunoassay for measuring human IgE. J. Allergy Clin. Immnol., 6, 23-27 (1978).
14. Druet, E., Mahieu, P., Foidart, J. M., and Druet, P.: Magnetic solid-phase enzyme immunoassay for the detection of anti-glomerular basement membrane antibodies. J. Immnol. Methods, 48, 149-157 (1982).
15. Pazzagli, M., Kohen, F., Sufi, S., Masironi, B., and Cekan, S. Z.: Immunometric assay for lutropin (hLH) based on the use of universal reagents for enzymatic labeling and magnetic separation and monitored by enhanced chemiluminescence. J. Immunol. Methods, 114, 62-68 (1988).
16. Vonk, G. P. and Schram, J. L.: Dual-enzyme cascade-magnetic separation immunoassay for respiratory syncytial virus. J. Immunol. Methods, 137, 133-139 (1991).
17. Shinkai, M., Wang, J., Kamihira, M., Iwata, M., Honda, H., and Kobayashi, T.: Rapid enzyme-linked immunosorbent assay with functional magnetite particles. J. Ferment. Bioeng., 73, 166-168 (1992).
18. Nagatani, N., Shinkai, M., Honda, H., and Kobayashi, T.: Development of a new transformation method using magnetite cationic liposomes and magnetic selection of transformed cells. Biotechnol. Lett., 22, 999-1002 (2000).
19. Padmanabhan, R., Corsico, C. D., Howard, T. H., Holter, W., Fordis, C. M., Willingham, M., and Howard, B. H.: Purification of transiently transfected cells by magnetic affinity cell sorting. Anal. Biochem., 170, 341-348 (1988).
20. Schneider, S. and Rusconi, S.: Magnetic selection of transiently transfected cells. Biotechniques, 21, 876-880 (1996).
21. Bergemann, C., Müller-Schulte, D., Oster, J., à Brassard, L., and Lübbe, A. S.: Magnetic ion-exchange nano- and microparticles for medical, biochemical and molecular biological applications. J. Magn. Magn. Matel., 194, 45-52 (1999).
22. Magin, R. L., Wright, S. M., Niesman, M. R., Chan, H. C., and Swartz, H. M.: Liposome delivery of NMR contrast agents for improved tissue imaging. Magn. Reson. Med., 3, 440-447 (1986).
23. Gillis, P. and Koenig, S. H.: Transverse relaxation of solvent protons induced by magnetized spheres: application to ferritin, erythrocytes, and magnetite. Magn. Reson. Med., 5, 323-345 (1987).
24. Saini, S., Stark, D. D., Hahn, P. F., Wittenberg, J., Brady, T. J., and Ferrucci, J. T.: Ferrite particles: a superparamagnetic MR contrast agent for the reticuloendothelial system. Radiology, 162, 211-216 (1987).
25. Stark, D. D., Weissleder, R., Elizondo, G., Hahn, P. F., Saini, S., Todd, L. E., Wittenberg, J., and Ferrucci, J. T.: Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver. Radiology, 168, 297-301 (1988).
26. Suzuki, M., Honda, H., Kobayashi, T., Wakabayashi, T., Yoshida, J., and Takahashi, M.: Development of a target-directed magnetic resonance contrast agent using monoclonal antibody-conjugated magnetic particles. Brain Tumor Pathol., 13, 127-132 (1996).
27. Shinkai, M., Ohshima, A., Yanase, M., Uchiyama, T., Mohri, K., Wakabayashi, T., Yoshida, J., Honda, H., and Kobayashi, T.: Development of novel magnetic sensing for brain lesion using functional magnetic particles. Kagaku Kougaku Ronbunshu, 24, 174-178 (1998).
28. Uchiyama, T., Mohri, K., Shinkai, M., Ohshima, A., Honda, H., Kobayashi, T., Wakabayashi, T., and Yoshida, J.: Basic study for brain tumor position sensing using amorphous wire MI micro magnetic sensor. Trans. IEE, Jpn., 119-C, 545-553 (1999).
29. Cavaliere, R., Ciocatto, E. C., Giovanella, B. C., Heidelburger, C., Jonson, R. O., Margottini, M., Mondovi, B., Moricca, B. G., and Rossi-Fanelli, A.: Selective heat sensitivity of cancer cells. Biochemical and clinical studies. Cancer, 20, 1351-1381 (1967).
30. Stauffer, P. R., Cetas, T. C., Fletcher, A. M., DeYoung, D. W, Dewhirst, M. W., Oleson, J. R., and Roemer, R. B.: Observations on the use of ferromagnetic implants for inducing hyperthermia. IEEE Trans. Biomed. Eng., 31, 76-90 (1984).
31. Lin, J. C. and Wang, Y. J.: Interstitial microwave antennas for thermal therapy. Int. J. Hyperthermia, 3, 37-47 (1987).
32. Ikeda, N., Hayashida, O., Kameda, H., Ito, H., and Matsuda, T.: Experimental study on thermal damage to dog normal brain. Int. J. Hyperthermia, 10, 553-561 (1994).
33. Jordan, A., Wust, P., Fähling, H., John, W., Hinz, A., and Felix, R.: Inductive heating of ferrimagnetic particles and magnetic fluids: physical evaluation of their potential for hyperthermia. Int. J. Hyperthermia, 9, 51-68 (1993).
34. Mitsumori, M., Hiraoka, M., Shibata, T., Okuno, Y., Nagata, Y., Nishimura, Y., Abe, M., Hasegawa, M., Nagae, H., and Ebisawa, Y.: Development of intra-arterial hyperthermia using a dextran-magnetite complex. Hepatogastroenterology, 43, 1431-1437 (1996).
35. Wada, S., Yue, L., Tazawa, K., Furuta, I., Nagae, H., Takemori, S., and Minamimura, T.: New local hyperthermia using dextran magnetite complex (DM) for oral cavity: experimental study in normal hamster tongue. Oral Dis., 7, 192-195 (2001).
36. Gordon, R. T., Hines, J. R., and Gordon, D.: Intracellular hyperthermia. A biophysical approach to cancer treatment via intracellular temperature and biophysical alterations. Med. Hypothesis, 5, 83-102 (1979).
37. Jordan, A., Wust, P., Scholz, R., Tesch, B., Fähling, H., Mitrovics, T., Vogl, T., Cervós-Navarro, J., and Felix, R.: Cellular uptake of magnetic fluid particles and their effects on human adenocarcinoma cells exposed to AC magnetic fields in vitro. Int. J. Hyperthermia, 12, 705-722 (1996).
38. Chan, D. C. F., Kirpotin, D. B., and Bunn, P. A.: Synthesis and evaluation of colloidal magnetic iron-oxides for the site-specific radiofrequency-induced hyperthermia of c ancer. J. Magn. Magn. Mater., 122, 374-378 (1993).
39. Shinkai, M., Matsui, M., and Kobayashi, T.: Heat properties of magnetoliposomes for local hyperthermia. Jpn. J. Hyperthermic Oncol., 10, 168 (1994).
40. Shinkai, M., Yanase, M., Honda, H., Wakabayashi, T., Yoshida, J., and Kobayashi, T.: Intracellular hyperthermia for cancer using magnetite cationic liposome: in vitro study. Jpn. J. Cancer Res., 87, 1179-1183 (1996).
41. Suzuki, M., Shinkai, M., Honda, H., and Kobayashi, T.: Anticancer effect and immune induction by hyperthermia of malignant melanoma using magnetite cationic liposomes. Melanoma Res., 13, 129-135 (2003).
42. Yanase, M., Shinkai, M., Honda, H., Wakabayashi, T., Yoshida, J., and Kobayashi, T.: Intracellular hyperthermia for cancer using magnetite cationic liposomes: an in vivo study. Jpn. J. Cancer Res., 89, 463-469 (1998).
43. Matsuoka, F., Shinkai, M., Honda, H., Kubo, T., Sugita, T., and Kobayashi, T.: Hyperthermia using magnetite cationic liposomes for hamster osteosarcoma. Biomagn. Res. Technol., 2, 3 (2004).
44. Matsuno, H., Tohnai, I., Mitsudo, K., Hayashi, Y., Ito, M., Shinkai, M., Kobayashi, T., Yoshida, J., and Ueda, M.: Interstitial hyperthermia using magnetite cationic liposomes inhibit to tumor growth of VX-7 transplanted tumor in rabbit tongue. Jpn. J. Hyperthermic Oncol., 17, 141-149 (2001).
45. Ito, A., Tanaka, K., Honda, H., Abe, S., Yamaguchi, H., and Kobayashi, T.: Complete regression of mouse mammary carcinoma with a size greater than 15 mm by frequent repeated hyperthermia using magnetite nanoparticles. J. Biosci. Bioeng., 96, 364-369 (2003).
46. Le, B., Shinkai, M., Kitade, T., Honda, H., Yoshida, J., Wakabayashi, T., and Kobayashi, T.: Preparation of tumor-specific magnetoliposomes and their application for hyperthermia. J. Chem. Eng. Jpn., 34, 66-72 (2001).
47. Shinkai, M., Le, B., Honda, H., Yoshikawa, K., Shimizu, K., Saga, S., Wakabayashi, T., Yoshida, J., and Kobayashi, T.: Targeting hyperthermia for renal cell carcinoma using human MN antigen-specific magnetoliposomes. Jpn. J. Cancer Res., 92, 1138-1145 (2001).
48. Yanase, M., Shinkai, M., Honda, H., Wakabayashi, T., Yoshida, J., and Kobayashi, T.: Antitumor immunity induction by intracellular hyperthermia using magnetite cationic liposomes. Jpn. J. Cancer Res., 89, 775-782 (1998).
49. Ito, A., Shinkai, M., Honda, H., Wakabayashi, T., Yoshida, J., and Kobayashi, T.: Augmentation of MHC class I antigen presentation via heat shock protein expression by hyperthermia. Cancer Immmunol. Immunother., 50, 515-522 (2001).
50. Ito, A., Shinkai, M., Honda, H., Yoshikawa, K., Saga, S., Wakabayashi, T., Yoshida, J., and Kobayashi, T.: Heat shock protein 70 expression induces antitumor immunity during intracellular hyperthermia using magnetite nanoparticles. Cancer Immunol. Immunother., 52, 80-88 (2003).
51. Ito, A., Honda, H., and Kobayashi, T.: Cancer immunotherapy based on intracellular hyperthermia using magnetite nanoparticles: a novel concept of "heat-controlled necrosis" with heat shock protein expression. Cancer Immunol. Immunother. (2005). (in press)
52. Schlesinger, M. J.: Heat shock proteins. J. Biol. Chem., 265, 12111-12114 (1990).
53. Mosser, D. D., Caron, A. W., Bourget, L., Meriin, A. B., Sherman, M. Y., Morimoto, R. I., and Massie, B.: The chaperone function of hsp70 is required for protection against stress-induced apoptosis. Mol. Cell. Biol., 20, 7146-7159 (2000).
54. Ménoret, A. and Chandawarkar, R.: Heat-shock protein-based anticancer immunotherapy: an idea whose time has come. Semin. Immunol., 25, 654-660 (1998).
55. Srivastava, P. K., Ménoret, A., Basu, S., Binder, R., and Quade, K.: Heat shock proteins come of age: primitive functions acquire new roles in an adaptive world. Immunity, 8, 657-665 (1998).
56. Srivastava, P. K. and Maki, R. G.: Stress-induced proteins in immune response to cancer. Curr. Top. Microbiol. Immunol., 167, 109-123 (1991).
57. Srivastava, P. K. and Heike, M.: Tumor-specific immunogenicity of stress-induced proteins: convergence of two evolutionary pathways of antigen presentation? Semin. Immunol., 3, 57-64 (1993).
58. Srivastava, P. K., Udono, H., Blachere, N. E., and Li, Z.: Heat shock proteins transfer peptides during antigen processing and CTL priming. Immunogenetics, 39, 93-98 (1994).
59. Wells, A. D. and Malkovsky, M.: Heat shock proteins, tumor immunogenicity and antigen presentation: an integrated view. Immunol. Today, 21, 129-132 (2000).
60. Wells, A. D., Rai, S. K., Salvato, M. S., Band, H., and Malkovsky, M.: Hsp72-mediated augmentation of MHC class I surface expression and endogenous antigen presentation. Int. Immunol., 10, 609-617 (1998).
61. Basu, S., Binder, R. J., Ramalingam, T., and Srivastava, P. K.: CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity, 14, 303-313 (2001).
62. Asea, A., Kraeft, S. K., Kurt-Jones, E. A., Stevenson, M. A., Chen, L. B., Finberg, R. W., Koo, G. C., and Calderwood, S. K.: HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat. Med., 6, 435-442 (2000).
63. Belli, F., Testori, A., Rivoltini, L., Maio, M., Andreola, G., Sertoli, M. R., Gallino, G., Piris, A., Cattelan, A., Lazzari, I., and other 19 authors: Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes: clinical and immunologic findings. J. Clin. Oncol., 20, 4169-4180 (2002).
64. Udono, H. and Srivastava, P. K.: Heat shock protein 70-associated peptides elicit specific cancer immunity. J. Exp. Med., 178, 1391-1396 (1993).
65. Ito, A., Tanaka, K., Kondo, K., Shinkai, M., Honda, H., Matsumoto, K., Saida, T., and Kobayashi, T.: Tumor regression by combined immunotherapy and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma. Cancer Sci., 94, 308-313 (2003).
66. Ito, A., Shinkai, M., Honda, H., and Kobayashi, T.: Heat-inducible TNF-alpha gene therapy combined with hyperthermia using magnetic nanoparticles as a novel tumor-targeted therapy. Cancer Gene Ther., 8, 649-654 (2001).
67. Ito, A., Matsuoka, F., Honda, H., and Kobayashi, T.: Antitumor effects of combined therapy of recombinant heat shock protein 70 and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma. Cancer Immunol. Immunother., 53, 26-32 (2004).
68. Ito, A., Matsuoka, F., Honda, H., and Kobayashi, T.: Heat shock protein 70 gene therapy combined with hyperthermia using magnetic nanoparticles. Cancer Gene Ther., 10, 918-925 (2003).
69. Tanaka, K., Ito, A., Kobayashi, T., Kawamura, T., Shimada, S., Matsumoto, K., Saida, T., and Honda, H.: Intratumoral injection of immature dendritic cells enhances antitumor effect of hyperthermia using magnetic nanoparticles. Int. J. Cancer, 116, 624-633 (2005).
70. Langer, R. and Vacanti, J. P.: Tissue engineering. Science, 260, 920-926 (1993).
71. Ito, A., Hayashida, M., Honda, H., Hata, K., Kagami, H., Ueda, M., and Kobayashi, T.: Construction and harvest of multilayered keratinocyte sheets using magnetite nanoparticles and magnetic force. Tissue Eng., 10, 873-880 (2004).
72. Yannas, I. V., Burke, J. F., Orgill, D. P., and Skrabut, E. M.: Wound tissue can utilize a polymeric template to synthesize a functional extension of skin. Science, 215, 174-176 (1982).
73. Bell, E., Ehrlich, H. P., Buttle, D. J., and Nakatsuji, T.: Living tissue formed in vitro and accepted as skin-equivalent tissue of full thickness. Science, 211, 1052-1054 (1981).
74. Houssaint, E.: Differentiation of the mouse hepatic primordium. I. An analysis of tissue interactions in hepatocyte differentiation. Cell Differ., 9, 269-279 (1980).
75. Douarin, N. M.: An experimental analysis of liver development. Med. Biol., 53, 427-455 (1975).
76. Bhatia, S. N., Yarmush, M. L., and Toner, M.: Controlling cell interactions by micropatterning in cocultures: hepatocytes and 3T3 fibroblasts. J. Biomed. Mater. Res., 34, 189-199 (1997).
77. Yamato, M., Kwon, O. H., Hirose, M., Kikuchi, A., and Okano, T.: Novel patterned cell coculture utilizing thermally responsive grafted polymer surfaces. J. Biomed. Mater. Res., 55, 137-140 (2001).
78. Ito, A., Takizawa, Y., Honda, H., Hata, K., Kagami, H., Ueda, M., and Kobayashi, T.: Tissue engineering using magnetite nanoparticles and magnetic force: heterotypic layers of cocultured hepatocytes and endothelial cells. Tissue Eng., 10, 833-840 (2004).
79. Ito, A., Hibino, E., Honda, H., Hata, K., Kagami, H., Ueda, M., and Kobayashi, T.: A new methodology of mesenchymal stem cell expansion using magnetic nanoparticles. Biochem. Eng. J., 20, 119-125 (2004).
80. Ito, A., Hibino, E., Kobayashi, C., Terasaki, H., Kagami, H., Ueda, M., Kobayashi, T., and Honda, H.: Construction and delivery of tissue-engineering human retinal pigment epithelial cell sheets using magnetite nanoparticles and manetic force. Tissue Eng., 11, 489-496 (2005).